⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RAPP News
Rapport Therapeutics, Inc. Common Stock
Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
RAPP
Rapport Therapeutics与Tenacia Biotechnology宣布达成大中华区RAP-219开发与商业化战略合作
globenewswire.com
RAPP
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
globenewswire.com
RAPP
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
globenewswire.com
RAPP
Rapport Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
RAPP
Rapala VMC and Okuma Announce New Distribution Agreement in Australia
globenewswire.com
RAPP
Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline
globenewswire.com
RAPP
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
RAPP
Rapala VMC Corporation adds Q1 and Q3 business reviews to its financial reporting in 2026
globenewswire.com
RAPP
Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures
globenewswire.com
RAPP